AQST Fair Value — Aquestive Therapeutics Inc

Pharmaceuticals · Institutional-depth multi-model valuation on Equity Rank

Current Price
$5.04
Consensus Fair Value
$4.19
Margin of Safety
-16.9%

When does AQST report earnings?

Aquestive Therapeutics Inc (AQST) is next scheduled to report earnings on Aug 10, 2026. The consensus analyst EPS estimate for the upcoming quarter is $-0.10.

Heading into this report, the model's fair value estimate sits 16.9% above the current price (model fair value differential below current price). Descriptive context only — not a forecast of the earnings result.

Earnings dates and estimates are sourced from third-party data and may change or lag. Informational only.

How AQST's valuation models agree

Equity Rank computed model fair value for AQST from 2 independent valuation methods with sufficient data. 0 place fair value above the current price of $5.04, and 2 place it below. The model-blended estimate lands at $4.19 — a model fair value differential of 16.9% below the current price under these model assumptions. The larger group places fair value below the current price.

Models: FV above price
0
Models: FV below price
2
Models compared
2

Each method (DCF, Graham Number, EPV, Three-Stage DCF, DDM, Residual Income, Justified Price-to-Book, and more) is weighted by historical sector accuracy. Model-derived and informational only — not investment advice.

AQST fundamental profile

Equity Rank's fundamental strength composite scores AQST at 34.6/100 (D+, Mixed), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, gross margin has moved +2.1 pp.

A composite quality metric for research context — not a rating, recommendation, or directional signal.

About AQST

Aquestive Therapeutics Inc (AQST) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.

Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.

Related Stocks in Pharmaceuticals

JNJ · UNH · PFE · ABBV · MRK

Research Tools

Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator